I am a little ambivalent too; you google Leronlimab, you the FDA hit letter, google CytoDyn, you get the hold and investigations.
On the other hand I like the name Leronlimab and the name CytoDyn and if the Amarex situation turns out to be a BP corruption, then keeping those names could be good for us.